IP Library Granted Patent US 8,598,362
Granted Patent B2
US 8,598,362 · App. 13/315,005 · Granted Dec 3, 2013

Methods for the preparation of charged crosslinkers

Inventors: Wei Li (Acton, MA); Robert Yongxin Zhao (Lexington, MA)
Assignee: ImmunoGen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,598,362
App. No.
13/315,005
Granted
Dec 3, 2013
Kind
B2
Abstract

Processes for the preparation of charged crosslinkers bearing a sulfonic acid moiety are disclosed. These procedures also optionally include methods to convert the resulting products to substantially a single salt form.

Claims (81)

1. A process for the preparation of a compound of formula (III):

or a salt thereof, comprising the step of reacting a compound of formula (II):

or a salt thereof, with a sulfonating agent, wherein:

Q represents a thiol-reactive moiety;

E represents a linear, branched or cyclic alkyl, alkenyl or alkynyl bearing 1 to 10 carbon atoms, a phenyl group, a three to six membered heterocycloalkyl group or a five or six-membered heteroaromatic group, containing 1, 2 or 3 heteroatoms selected from O, N or S;

F is an optional moiety that has the same definition as E; or when G is absent, F and R 1 together with the carbon atom from which they are attached can form a three to seven membered cycloalkyl group;

G is absent or represents -G′-(OCH 2 CH 2 ) n —, -G′-(CH 2 —CH 2 —O) n — or -(AA) m -;

G′ is absent, —C(═O)—NH— or —NH—C(═O)—,

AA represents an amino acid residue;

R 1 is —H or a linear, branched or cyclic alkyl, alkenyl or alkynyl bearing 1 to 10 carbon atoms;

n is 0 or an integer from 1 to 24; and

m is 0 or an integer from 1 to 6.

2. The process of claim 1 , wherein the sulfonating agent is chlorosulfonic acid or sulfur trioxide.

3. The process of claim 1 , wherein the sulfonating agent is chlorosulfonic acid.

4. The process of any one of claims 1 - 3 , wherein the sulfonating reaction is carried out in the presence of a base.

5. The process of claim 4 , wherein the base is triethyl amine, diisopropylethyl amine or tributyl amine.

6. The process of claim 5 , wherein the base is diisopropylethyl amine.

7. The process of claim 1 , wherein the process further comprises the step of purifying the compound of formula (III) obtained by the reaction.

8. The process of claim 7 , wherein the compound of formula (III) is purified by reverse phase chromatography.

9. The process of claim 1 , wherein G and F are both absent, E is a linear or branched alkyl bearing 1 to 4 carbon atoms.

10. The process of claim 9 , wherein E is —CH 2 —CH 2 —.

11. The process of claim 1 , wherein G is absent, and F and R 1 together with the carbon atom from which they are attached form a cyclohexyl group.

12. The process of claim 11 , wherein E is a linear or branched alkyl bearing 1 to 4 carbon atoms.

13. The process of claim 12 , wherein E is —CH 2 —.

14. The process of claim 1 , wherein Q is a disulfide group selected from alkyl disulfide, phenyl disulfide, ortho or para-nitrophenyl disulfide, 2,4-dintrophenyl disulfide, pyridyl disulfide, nitropyridyl disulfide; a maleimido group or a haloacetyl group.

15. The process of claim 14 , wherein Q is pyridyl disulfide or maleimido group.

16. The process of claim 14 , wherein Q is pyridyl disulfide.

17. The process of claim 1 , wherein the compound of formula (III) or a salt thereof is a compound of formula (IV):

or a salt thereof, and wherein the compound of formula (II) or a salt thereof is a compound of formula (2a):

or a salt thereof.

18. The process of claim 17 , wherein the sulfonating agent is chlorosulfonic acid or sulfur trioxide.

19. The process of claim 17 , wherein the sulfonating agent is chlorosulfonic acid.

20. The process of claim 17 , wherein the sulfonating reaction is carried out in the presence of 1,2-di(pyridin-2-yl)disulfane (PySSPy).

21. The process of claim 20 , wherein about 0.5 equivalent of PySSPy is present.

22. The process of claim 17 , wherein the process further comprises the step of purifying the compound of formula (IV) obtained by the reaction.

23. The process of claim 22 , wherein the compound of formula (IV) is purified by reverse phase chromatography.

24. The process of claim 22 , wherein the compound of formula (IV) is purified by using a silica column.

25. The process of claim 1 , further comprising

reacting the compound of formula (III) or a salt thereof, with a hydroxy or mercapto compound to form a compound of formula (I),

or a salt thereof, wherein C(═O)L represents a reactive ester or thioester group.

26. The process of claim 25 , wherein the sulfonating agent is chlorosulfonic acid or sulfur trioxide.

27. The process of claim 25 , wherein the sulfonating agent is chlorosulfonic acid.

28. The process of claim 25 , wherein the reaction between the compound of formula (III) and the hydroxy or mercapto compound is carried out in the presence of a coupling agent.

29. The process of claim 28 , wherein the coupling agent is selected from N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N,N′-diisopropyl carbodiimide (DIC) and 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

30. The process of claim 29 , wherein the coupling agent is EDC.

31. The process of claim 25 , wherein the reactive ester or thioester group is selected from N-hydroxysuccinimide ester, N-hydroxy sulfosuccinimide ester, nitrophenyl ester, tetrafluoro phenyl ester, pentafluorophenyl ester, a thiopyridyl ester and a thionitrophenyl ester.

32. The process of claim 31 , wherein the reactive ester is N-hydroxysuccinimide ester.

33. The process of claim 25 , further comprising the step of purifying the compound of formula (III) or a salt thereof.

34. The process of claim 33 , wherein the compound of formula (III) or a salt thereof is purified by reverse phase chromatography.

35. The process of claim 25 , further comprising the step of purifying the compound of formula (I).

36. The process of claim 35 , wherein the compound of formula (I) is purified by reverse phase chromatography.

37. The process of claim 25 , wherein G and F are both absent, E is a linear or branched alkyl bearing 1 to 4 carbon atoms.

38. The process of claim 37 , wherein E is —CH 2 —CH 2 —.

39. The process of claim 25 , wherein G is absent, and F and R 1 together with the carbon atom from which they are attached form a cyclohexyl group.

40. The process of claim 39 , wherein E is a linear or branched alkyl bearing 1 to 4 carbon atoms.

41. The process of claim 40 , wherein E is —CH 2 —.

42. The process of claim 25 , wherein Q is a disulfide group selected from alkyl disulfide, phenyl disulfide, ortho or para-nitrophenyl disulfide, 2,4-dintrophenyl disulfide, pyridyl disulfide, nitropyridyl disulfide; a maleimido group or a haloacetyl group.

43. The process of claim 42 , wherein Q is pyridyl disulfide or maleimido group.

44. The process of claim 42 , wherein Q is pyridyl disulfide.

45. The process of claim 17 , further comprising preparation of a compound represented by formula (V):

reacting the compound of formula (IV) or a salt thereof, with N-hydroxysuccinimide to form the compound of formula (V),

or a salt thereof.

46. The process of claim 45 , wherein the sulfonating agent is chlorosulfonic acid or sulfur trioxide.

47. The process of claim 45 , wherein the sulfonating agent is chlorosulfonic acid.

48. The process of claim 45 , wherein the sulfonating reaction is carried out in the presence of PySSPy.

49. The process of claim 48 , wherein about 0.5 equivalent of PySSPy is present.

50. The process of claim 45 , wherein the reaction between the compound of formula (IV) and N-hydroxysuccinimide is carried out in the presence of a coupling agent.

51. The process of claim 50 , wherein the coupling agent is selected from N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N,N′-diisopropyl carbodiimide (DIC) and 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

52. The process of claim 51 , wherein the coupling agent is EDC.

53. The process of claim 45 , wherein the reaction between the compound of formula (IV) and N-hydroxysuccinimide is carried in the presence of a base.

54. The process of claim 53 , wherein the base is diisopropylethylamine (DIPEA).

55. The process of claim 45 , wherein the process comprises the steps of:

a) reacting the compound of formula (2a) or a salt thereof with chlorosulfonic acid to form the compound of formula (IV); and

b) reacting the compound of formula (IV) with N-hydroxysuccinimide in the presence of EDC to form the compound of formula (V).

56. The process of claim 45 , further comprising the step of purifying the compound of formula (IV) or a salt thereof.

57. The process of claim 56 , wherein the compound of formula (IV) or a salt thereof is purified by reverse phase chromatography.

58. The process of claim 56 , wherein the compound of formula (IV) or a salt thereof is purified by using a silica column.

59. The process of claim 45 , further comprising the step of purifying the compound of formula (V) or a salt thereof.

60. The process of claim 59 , wherein the compound of formula (V) or a salt thereof is purified by reverse phase chromatography.

61. The process of claim 59 , wherein the compound of formula (V) or a salt thereof is purified by using a silica column.

62. The process of claim 59 , wherein the compound of formula (V) or a salt thereof is purified by crystallization.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →
PATENT SECURITY AGREEMENT Recorded Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2012
From: LI, WEI; ZHAO, ROBERT YONGXIN
To: IMMUNOGEN, INC.
Reel/Frame 027848/0801 →
Continuity (2)
Provisional Application 61421357 · Dec 9, 2010
Related Publication 20120165537A1 · Jun 28, 2012